{"id":407594,"date":"2021-01-04T09:03:58","date_gmt":"2021-01-04T14:03:58","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407594"},"modified":"2021-01-04T09:03:58","modified_gmt":"2021-01-04T14:03:58","slug":"mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/","title":{"rendered":"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price?"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SAN DIEGO<\/span>, <span class=\"xn-chron\">Jan. 4, 2021<\/span> \/PRNewswire\/ &#8212; Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Magellan Health, Inc. (NASDAQ: MGLN)\u00a0breached their fiduciary duties in connection with the proposed sale of the Company to Centene Corporation (NYSE: CNC).<\/p>\n<p>On <span class=\"xn-chron\">January 4, 2021<\/span>, Magellan Health announced that it had entered into a definitive merger agreement with Centene. Under the terms of the acquisition agreement, Magellan Health shareholders will receive <span class=\"xn-money\">$95.00<\/span> per share in cash.<\/p>\n<p>The investigation concerns whether the Magellan Health board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Magellan Health shares of common stock. Nationally recognized <span class=\"xn-person\">Johnson Fistel<\/span> is investigating whether the proposed deal represents adequate consideration, especially given analysts&#8217; projections for future earnings and revenue growth.\u00a0<\/p>\n<p>If you are a shareholder of Magellan Health and believe the proposed buyout price is too low or you&#8217;re interested in learning more about the investigation, please contact lead analyst <span class=\"xn-person\">Jim Baker<\/span> (<u><a target=\"_blank\" href=\"mailto:jimb@johnsonfistel.com\" rel=\"nofollow noopener noreferrer\">jimb@johnsonfistel.com<\/a><\/u>) at <a target=\"_blank\" href=\"tel:6198144471\" rel=\"nofollow noopener noreferrer\">619-814-4471<\/a>.\u00a0If emailing, please include a phone number.<\/p>\n<p>Additionally, you can [<b><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3025216-1&amp;h=2152064335&amp;u=https%3A%2F%2Fwww.cognitoforms.com%2FJohnsonFistel%2FMagellanHealthInc&amp;a=Click+here+to+join+this+action\" rel=\"nofollow noopener noreferrer\">Click here to join this action<\/a><\/b>]. There is no cost or obligation to you.<\/p>\n<p>About <span class=\"xn-person\">Johnson Fistel<\/span>, LLP:<br \/><span class=\"xn-person\">Johnson Fistel<\/span>, LLP is a nationally recognized shareholder rights law firm with offices in <span class=\"xn-location\">California<\/span>, <span class=\"xn-location\">New York<\/span>, and <span class=\"xn-location\">Georgia<\/span>. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3025216-1&amp;h=2601077397&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2877191-1%26h%3D2427651901%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D2863347-1%2526h%253D3519000358%2526u%253Dhttps%25253A%25252F%25252Fwww.johnsonfistel.com%25252F%2526a%253Dhttps%25253A%25252F%25252Fwww.johnsonfistel.com%26a%3Dhttps%253A%252F%252Fwww.johnsonfistel.com&amp;a=https%3A%2F%2Fwww.johnsonfistel.com\" rel=\"nofollow noopener noreferrer\">https:\/\/www.johnsonfistel.com<\/a>. Attorney advertising. Past results do not guarantee future outcomes.<\/p>\n<p>Contact:<br \/><span class=\"xn-person\">Johnson Fistel<\/span>, LLP<br \/><span class=\"xn-person\">Jim Baker<\/span>, <a target=\"_blank\" href=\"tel:6198144471\" rel=\"nofollow noopener noreferrer\">619-814-4471<\/a><br \/><a target=\"_blank\" href=\"mailto:jimb@johnsonfistel.com\" rel=\"nofollow noopener noreferrer\">jimb@johnsonfistel.com<\/a><\/p>\n<p>[<b><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3025216-1&amp;h=2152064335&amp;u=https%3A%2F%2Fwww.cognitoforms.com%2FJohnsonFistel%2FMagellanHealthInc&amp;a=Click+here+to+join+this+action\" rel=\"nofollow noopener noreferrer\">Click here to join this action<\/a><\/b>]<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH36504&amp;sd=2021-01-04\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price-301200238.html\">http:\/\/www.prnewswire.com\/news-releases\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price-301200238.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-person\">Johnson Fistel<\/span>, LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH36504&amp;Transmission_Id=202101040900PR_NEWS_USPR_____PH36504&amp;DateId=20210104\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SAN DIEGO, Jan. 4, 2021 \/PRNewswire\/ &#8212; Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Magellan Health, Inc. (NASDAQ: MGLN)\u00a0breached their fiduciary duties in connection with the proposed sale of the Company to Centene Corporation (NYSE: CNC). On January 4, 2021, Magellan Health announced that it had entered into a definitive merger agreement with Centene. Under the terms of the acquisition agreement, Magellan Health shareholders will receive $95.00 per share in cash. The investigation concerns whether the Magellan Health board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price?&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-407594","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price? - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price? - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO, Jan. 4, 2021 \/PRNewswire\/ &#8212; Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Magellan Health, Inc. (NASDAQ: MGLN)\u00a0breached their fiduciary duties in connection with the proposed sale of the Company to Centene Corporation (NYSE: CNC). On January 4, 2021, Magellan Health announced that it had entered into a definitive merger agreement with Centene. Under the terms of the acquisition agreement, Magellan Health shareholders will receive $95.00 per share in cash. The investigation concerns whether the Magellan Health board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for &hellip; Continue reading &quot;(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price?&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T14:03:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH36504&amp;sd=2021-01-04\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price?\",\"datePublished\":\"2021-01-04T14:03:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/\"},\"wordCount\":315,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH36504&amp;sd=2021-01-04\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/\",\"name\":\"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price? - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH36504&amp;sd=2021-01-04\",\"datePublished\":\"2021-01-04T14:03:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH36504&amp;sd=2021-01-04\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH36504&amp;sd=2021-01-04\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price? - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/","og_locale":"en_US","og_type":"article","og_title":"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price? - Market Newsdesk","og_description":"PR Newswire SAN DIEGO, Jan. 4, 2021 \/PRNewswire\/ &#8212; Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Magellan Health, Inc. (NASDAQ: MGLN)\u00a0breached their fiduciary duties in connection with the proposed sale of the Company to Centene Corporation (NYSE: CNC). On January 4, 2021, Magellan Health announced that it had entered into a definitive merger agreement with Centene. Under the terms of the acquisition agreement, Magellan Health shareholders will receive $95.00 per share in cash. The investigation concerns whether the Magellan Health board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for &hellip; Continue reading \"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price?\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-04T14:03:58+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH36504&amp;sd=2021-01-04","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price?","datePublished":"2021-01-04T14:03:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/"},"wordCount":315,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH36504&amp;sd=2021-01-04","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/","name":"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price? - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH36504&amp;sd=2021-01-04","datePublished":"2021-01-04T14:03:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH36504&amp;sd=2021-01-04","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH36504&amp;sd=2021-01-04"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mgln-alert-johnson-fistel-investigates-proposed-sale-of-magellan-health-is-95-a-fair-price\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"(MGLN) Alert: Johnson Fistel Investigates Proposed Sale of Magellan Health; Is $95 a Fair Price?"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=407594"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407594\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=407594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=407594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=407594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}